News and Comments

INCYTE: SHOWS ITS PATH TOWARDS GROWTH

  Wednesday, February 12, 2014

 More...

HALOZYME: FINANCING PEGPH20 IS WORTH RAISING MONEY

  Wednesday, February 05, 2014

Halozyme Therapeutics (HALO) stock has been a loser yesterday while other biotech firms have rebounded after dipping during the few days’ of an angry market. The reason for the stock decline was the announcement of pricing of Halozyme’s previously announced underwritten public offering of 7,692,307 shares of its common stock at a public offering price of $13.00 per share.  More...


Recent Postings


Archive


Tags

Valeant Pharmaceuticals International (VRX) Regeneron (REGN) Galena (GALE) GUARDIAN HEALTH Sanofi-Aventis (SAN) Zerenex Dendreon (DNDN) Vertex (VRTX) Ariad (ARIA) SUNESIS PHARMACEUTICALS (SNSS) Biocryst (BCRX) Inovio (INO) ABBVIE (ABBV) OSI (OSIP) Sanofi (SNA) Ionis (IONS) Anacor (ANAC) Roche (ROCHE) CompuGen (CGEN) Dynavax (DVAX) KITE (KITE) Herceptin Pluristem (PSTI) VANDA (VNDA) Endometrial Cancer SYNTA (SNTA) JUNO (JUNO) Sanofi (SNY) Intrexon (XON) Prolor Biotech (PBTH) Bristol-Myers Squibb (BMY) HALOZYME (HALO) Xoma (XOMA) Editas (EDIT) REGULUS (RGLS) Rapamune Anadys (ANDS) Elan (ELN) Amgen (AMGN) Human Genome Sciences (HGSI) Exelixis (EXEL) ADVENTRIX (ANX) BIOMARIN (BMRN) RenenxBio (RGNX) Theravance Bio Pharma (TBPH) IDERA (IDRA) Alnylam (ALNY) Incyte (INCY) TOKAI (TKAOI) Abbott Laboratories (ABT) Biogen Idec (BIIB) Micromet (MITI) ZALTRAP™ PTC Therapeutics (PTCT) Sequenom (SQNM) Prosensa (RNA) Human Longevity (HLI) C4 Therapeutics Vitae Pharmaceuticals (VTAE) Cytokinetics (CYTK) Alder Biopharmaceuticals (ALDR) Theravance (THRX) ARCA (ABIO) Multiple Myeloma Tysabri Seattle Genetics (SGEN) Intermune (ITMN) galapagos (GLPG) Revlimid (lenolidamide) Agenus (AGEN) KERYX (KERX) Array Pharmaceuticals (ARRY) Auspex (ASPX) Trastuzumab-DM1 Onyx (ONXX) Ziofpharm (ZIOP) AERIE PHARMACEUTICALS Merck (MRK) NEKTAR (NKTR)) Telaprevir GlaxoSmithKline (GSK) Benlysta (belimumab) Roche (RHHBY) Mirati Therapeutics (MRTX) Idenix (IDIX) ImmunoGen (IMGN) SERES THERAPEUTICS (MCRB) ACADIA (ACAD) Ridaforolimus Intercept (ICPT) Aimmune Therapeutics (AIMT) Sangamo (SGMO) Jazz Pharmaceuticals (JAZZ) Genentech NANTKWEST (NK) Gilead (GILD) Illumina (ILMN) ISIS (ISIS) Agenus (AGEN Sarepta (SRPT) Velcade (bortezomib)